Methionine adenosyltransferase 1-3 deficiency

Methionine adenosyltransferase I/III (MAT I/III) deficiency is an inherited disorder of methionine metabolism caused by variants in the MAT1A gene. It produces persistent hypermethioninemia, usually isolated and benign in course, although some biallelic cases may be associated with decreased S-adenosylmethionine (SAM) and neurological manifestations.

The MAT1A gene encodes the hepatic methionine adenosyltransferase I and III isoenzymes, which catalyze the conversion of methionine into S-adenosylmethionine (SAM), the body's main methyl group donor. SAM participates in numerous methylation reactions, including neurotransmitter synthesis and processes related to central nervous system myelination.

Pathogenic variants in MAT1A reduce enzyme activity, leading to methionine accumulation in the blood, and in some patients, SAM levels may decrease. Unlike other causes of hypermethioninemia, it usually presents with normal or not significantly elevated homocysteine. The deficiency can be inherited in an autosomal dominant or autosomal recessive manner: dominant forms are usually mild or asymptomatic, while recessive forms due to biallelic variants carry a higher risk of neurological or hepatic manifestations. Many cases are detected through newborn screening.

Symptoms

The onset usually corresponds to the neonatal period due to detection in screening, although most individuals remain asymptomatic. When clinical manifestations appear, they may include developmental delay, language disorders, hypotonia, learning problems, movement disorders, or seizures. In some biallelic cases, cerebral demyelination has been described; liver involvement, such as steatosis or cirrhosis, is infrequent.

Disease management

There is no specific preventive strategy to avoid the genetic disease, but monitoring aims to prevent complications associated with very high methionine or SAM deficiency. In mild cases, periodic monitoring of methionine, homocysteine, and neurological evolution may suffice. If methionine is persistently very high or symptoms exist, moderate methionine restriction may be indicated and, in selected cases, supplementation with SAM under specialized supervision.

Genes analyzed

MAT1A U
U Ultra Whole Genome Sequencing 30x

Bibliography

Furujo M, Kinoshita M, Nagao M, et al. Methionine adenosyltransferase I/III deficiency: neurological manifestations and relevance of S-adenosylmethionine. Mol Genet Metab. 2012 Nov;107(3):253-6.

Kim YM, Kim JH, Choi J, et al. Determination of Autosomal Dominant or Recessive Methionine Adenosyltransferase I/III Deficiencies Based on Clinical and Molecular Studies. Mol Med. 2016 Sep;22:147-155.

Muriello MJ, Viall S, Bottiglieri T, et al. Confirmation that MAT1A p.Ala259Val mutation causes autosomal dominant hypermethioninemia. Mol Genet Metab Rep. 2017 Jul 15;13:9-12.

What do your genes say about you? Start your journey today.

Get a special 5% discount on your first kit.

Haven't you taken our DNA test yet?

Get your genetic test and discover what your DNA says about you.

pack
Starter DNA test
The best option to get started

Ancestry service, Traits and Wellness

Buy
pack
DNA test Advanced DNA test
Know your DNA in depth

Health, Ancestry service, Traits and Wellness

Buy
pack
Genetic analysisUltra
Whole Genome Sequencing 30x

Health, Ancestrality, Traits and Wellness

includes three months of tellmeGen+

Buy

Important information and limitations

Europe
Austria
Belgium
Czech Republic
Denmark
Finland
Germany
Hungary
Ireland
Italy
Netherlands
Norway
Poland
Portugal
Romania
Spain
Sweden
Switzerland
United Kingdom
Asia
Kazakhstan
Saudi Arabia
UAE
America
Brazil
Canada
Chile
Colombia
Mexico
Panama
Peru
United States
Oceania
Australia
The Best Prices of the Year! Only until November 27 Use our coupon BLACK15
Buy